This site is currently not optimized for mobile devices. For the best user experience, please access the site via a device with a wider screen such as a desktop or laptop.

For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Once enabled, click here to view the site.

signup link button why should I sign up?
Login as Volunteer Login as Study team member
OR

Studies you may be eligible for. 18

Based on the information you provided, we found the following studies.

  • A First-In-Human Study of Dosing with REGN2810 as Single Therapy and in Combination with Other Anti-Cancer Therapies in Patients with Advanced Malignancies Study purpose: find safe dose of REGN2810 given alone or in combination therapies;measure levels of REGN2810 in blood; evaluate if REGN2810 given alone or in combination w/other therapies will cause tumor shrinkage;test different dose levels of REGN2810, radiotherapy, GM-CSF, and cyclophosphamide. This study is researching all of the following topics: Bladder cancer Breast cancer Cervical cancer Colorectal / Colon / Rectal cancer Esophagus cancer HCC, Liver cancer Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer Oral / Mouth cancer Ovarian cancer Pancreatic cancer Prostate cancer Stomach cancer, Gastric cancer ( Malignant tumor of stomach ) Thyroid cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Phase II study of ponatinib for advanced cancers with genomic alterations in fibroblastic growth factor receptor (FGFR) and other genomic targets (KIT, PDGFRa, RET FLT3, ABL1) The purpose of this study is to find out what effects; good and/or bad, ponatinib has on you and your cancer. Your body has proteins that are involved in a cancer’s ability to grow and survive. The drug, Ponatinib, may prevent these proteins from causing cancer growth. This study is researching all of the following topics: Bladder cancer Breast cancer Colon Cancer ( Malignant tumor of colon ) Colorectal / Colon / Rectal cancer Esophagus cancer Kidney Cancer ( Malignant tumor of kidney ) Lung cancer Ovarian cancer Pancreatic cancer Prostate cancer Thyroid cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A PHASE 1/2 OPEN-LABEL STUDY TO ASSESS THE SAFETY, PHARMACOKINETICS, AND ANTI-TUMOR ACTIVITY OF ORAL EPI-506 IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER The purpose of the Study is: •To find the highest dose of EPI-506 that can be given without causing severe side effects •To find out the side effects seen by giving EPI-506 at different doses •To measure the amount of EPI-506 (and/or its chemical relative EPI-002) in the blood at different doses This study is researching all of the following topics: Prostate cancer This study is looking for: male only men Volunteers with specific conditions
    • More than 18 years old
  • A Phase 1, Open-label, Dose Escalation, Safety and Tolerability Study of Investigational Drug INCB054828 in Subjects with Advanced Malignancies Study goals: determine dose that is safe and tolerable in people with advanced cancer and select the doses that will be studied further; see how INCB054828 acts on and in the body; see effect INCB054828 has on the growth of your cancer; see action of INCB054828 in the body over a period of time This study is researching all of the following topics: Bladder cancer Cervical cancer Colon Cancer ( Malignant tumor of colon ) Colorectal / Colon / Rectal cancer Kidney Cancer ( Malignant tumor of kidney ) Lung cancer Multiple myeloma Prostate cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Ph 2 Randomized Double-Blind Study of Salvage Radiation Therapy (SRT) Plus Placebo Versus SRT Plus Enzalutamide in Men with High-Risk PSA-Recurrent Prostate Cancer after Radical Prostatectomy This research is being done to study the safety and effectiveness of adding a study drug called enzalutamide to radiation treatments for men, who have rising PSA levels following prostatectomy surgery. This study is researching all of the following topics: Prostate cancer This study is looking for: male only men Volunteers with specific conditions
    • More than 18 years old
  • Ph 3 Randomized/Open-Label/Multi-Ctr/Controlled Study: Galeterone Compared to Enzalutamide in Men Expressing Androgen Receptor Splice Variant-7 mRNA with Metastatic Castrate Resistant Prostate Cancer Study goals: compare time it takes for tumors to grow in patients who receive galeterone compared to standard treatment enzalutamide; compare other effects such as quality of life, degree of pain, time before starting another cancer therapy, decreases in PSA and evaluation of tumor shrinkage. This study is researching all of the following topics: Prostate cancer This study is looking for: male only men Volunteers with specific conditions
    • More than 18 years old
  • Phase 1, Open-Label, Dose-Escalation, Safety and Tolerability Study of investigational drug INCB054329 (Study Drug) in Subjects With Advanced Malignancies (INCB 54329-101) Study purpose:determine dose that is safe and tolerable and select the doses that will be studied further;understand how INCB054329 enters and leaves the body over time;understand how INCB054329 acts on and in the body;observe any effects INCB054329 may have on the growth of certain types of cancers This study is researching all of the following topics: ALL ( Acute lymphoblastic leukemia ) Breast cancer CLL ( Chronic lymphocytic leukemia) Colon Cancer ( Malignant tumor of colon ) Lung cancer Pancreatic cancer Prostate cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Randomized Phase II Study Comparing Bipolar Androgen Therapy vs. Enzalutamide in Asymptomatic Men with Castration Resistant Metastatic Prostate Cancer: The TRANSFORMER Trial Study goals: test whether men with prostate cancer that is getting worse after treatment with hormone therapy and abiraterone respond better to testosterone or enzalutamide; determine if subjects have a better response to enzalutamide after testosterone compared to response after abiraterone. This study is researching all of the following topics: Prostate cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase I Multicenter, Open-label, Dose-Escalation Study of Oral LEE011 in Patients with Advanced Solid Tumor or Lymphomas This study will evaluate the safety of an investigational drug called LEE011 administered to adult patients with advanced malignant solid tumors or lymphomas. This study is researching all of the following topics: Breast cancer Colon Cancer ( Malignant tumor of colon ) Kidney Cancer ( Malignant tumor of kidney ) Lung cancer Lymphoma Melanoma Other Prostate cancer Sarcoma This study is looking for: male female both men and women Volunteers with specific conditions
    • All ages welcome
  • A Survey of Cancer Survivors Treatment Preferences for Cancer-Related Fatigue The purpose of our study is to see how cancer patients and survivors would like to learn about acupressure or diet as a treatment for their cancer symptoms like fatigue as well as general information about technology used and their environment. This study is researching all of the following topics: Adrenal cancer BCC, Basal cell skin cancer Bile duct cancer Bladder cancer Bone cancer Brain cancer Breast cancer Cancerous bone tumor, Osteosarcoma Cervical cancer Colon Cancer ( Malignant tumor of colon ) Colorectal / Colon / Rectal cancer Esophagus cancer Fallopian tube cancer HCC, Liver cancer HNPCC, Lynch Syndrome ( Hereditary NonPolyposis Colorectal Cancer ) Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer NPC, Nasal cancer Oral / Mouth cancer Ovarian cancer Pancreatic cancer PPC, Primary peritoneal cancer Prostate cancer Salivary Gland Cancer Skin Cancer ( Malignant neoplasm of skin ) Squamous cell skin cancer Thyroid cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions and Healthy volunteers
    • More than 18 years old
Showing 1-10 of 18 studies
Show more studies